Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Healthcare Providers' and Frontline Workers' Experiences of an Ebola Vaccine Trial in the Boende Health District of the Democratic Republic of the Congo.
Zola Matuvanga T, Bolombo FB, Paviotti A, Larivière Y, Lemey G, Salloum M, Osang'ir BI, Matangila J, Maketa V, Esanga E, Milolo S, Mitashi P, Van Damme P, Muhindo-Mavoko H, Van Geertruyden JP. Zola Matuvanga T, et al. Among authors: lariviere y. Am J Trop Med Hyg. 2024 Jul 2;111(3):578-588. doi: 10.4269/ajtmh.23-0581. Print 2024 Sep 4. Am J Trop Med Hyg. 2024. PMID: 38955200 Free PMC article.
An ancillary care policy in a vaccine trial conducted in a resource-constrained setting: evaluation and policy recommendations.
Lemey G, Larivière Y, Osang'ir BI, Zola T, Kimbulu P, Milolo S, Danoff E, Tchuma Y, Maketa V, Mitashi P, Ravinetto R, Van Damme P, Van Geertruyden JP, Muhindo-Mavoko H. Lemey G, et al. Among authors: lariviere y. BMJ Glob Health. 2024 Jun 10;9(6):e015259. doi: 10.1136/bmjgh-2024-015259. BMJ Glob Health. 2024. PMID: 38857947 Free PMC article. Clinical Trial.
Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, randomised, phase 2 trial.
Larivière Y, Matuvanga TZ, Osang'ir BI, Milolo S, Meta R, Kimbulu P, Robinson C, Katwere M, McLean C, Lemey G, Matangila J, Maketa V, Mitashi P, Van Geertruyden JP, Van Damme P, Muhindo-Mavoko H. Larivière Y, et al. Lancet Infect Dis. 2024 Jul;24(7):746-759. doi: 10.1016/S1473-3099(24)00058-6. Epub 2024 Mar 26. Lancet Infect Dis. 2024. PMID: 38552653 Clinical Trial.
Longitudinal assessment of an Ebola vaccine trial understanding among healthcare providers in the Democratic Republic of the Congo.
Zola Matuvanga T, Larivière Y, Lemey G, Isekah Osang'ir B, Mariën J, Milolo S, Meta R, Matangila J, Maketa V, Mitashi P, Van Geertruyden JP, Muhindo-Mavoko H, Van Damme P. Zola Matuvanga T, et al. Among authors: lariviere y. Vaccine. 2024 Jan 25;42(3):481-488. doi: 10.1016/j.vaccine.2023.12.076. Epub 2023 Dec 31. Vaccine. 2024. PMID: 38163747 Free article.
Conducting an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.
Larivière Y, Matuvanga TZ, Lemey G, Osang'ir BI, Vermeiren PP, Milolo S, Meta R, Kimbulu P, Esanga E, Matangila J, Van Geertruyden JP, Van Damme P, Maketa V, Muhindo-Mavoko H, Mitashi P. Larivière Y, et al. Vaccine. 2023 Dec 12;41(51):7587-7597. doi: 10.1016/j.vaccine.2023.11.030. Epub 2023 Nov 22. Vaccine. 2023. PMID: 37993355 Free article.
Safety and Immunogenicity of the Heterologous 2-Dose Ad26.ZEBOV, MVA-BN-Filo Vaccine Regimen in Health Care Providers and Frontliners of the Democratic Republic of the Congo.
Larivière Y, Garcia-Fogeda I, Zola Matuvanga T, Isekah Osang'ir B, Milolo S, Meta R, Kimbulu P, Robinson C, Katwere M, McLean C, Hens N, Matangila J, Maketa V, Mitashi P, Muhindo-Mavoko H, Van Geertruyden JP, Van Damme P. Larivière Y, et al. J Infect Dis. 2024 Apr 12;229(4):1068-1076. doi: 10.1093/infdis/jiad350. J Infect Dis. 2024. PMID: 37673423 Free PMC article. Clinical Trial.
Low seroprevalence of Ebola virus in health care providers in an endemic region (Tshuapa province) of the Democratic Republic of the Congo.
Zola Matuvanga T, Mariën J, Larivière Y, Osang'ir BI, Milolo S, Meta R, Esanga E, Maketa V, Matangila J, Mitashi P, Ahuka Mundeke S, Muhindo-Mavoko H, Muyembe Tamfum JJ, Van Damme P, Van Geertruyden JP. Zola Matuvanga T, et al. Among authors: lariviere y. PLoS One. 2023 Sep 1;18(9):e0286479. doi: 10.1371/journal.pone.0286479. eCollection 2023. PLoS One. 2023. PMID: 37656725 Free PMC article.
Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.
Zola Matuvanga T, Larivière Y, Lemey G, De Bie J, Milolo S, Meta R, Esanga E, Vermeiren PP, Thys S, Van Geertruyden JP, Van Damme P, Maketa V, Matangila J, Mitashi P, Muhindo-Mavoko H. Zola Matuvanga T, et al. Among authors: lariviere y. Vaccine. 2022 May 31;40(25):3470-3480. doi: 10.1016/j.vaccine.2022.04.094. Epub 2022 May 9. Vaccine. 2022. PMID: 35550847 Free article.
15 results